CATALOGO DEI PRODOTTI DELLA RICERCA

MAGLIOZZI, Roberta
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.166
EU - Europa 3.837
AS - Asia 3.355
SA - Sud America 537
AF - Africa 132
OC - Oceania 12
Totale 12.039
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.055
RU - Federazione Russa 1.688
SG - Singapore 1.330
CN - Cina 908
GB - Regno Unito 549
IT - Italia 464
BR - Brasile 417
VN - Vietnam 344
HK - Hong Kong 318
SE - Svezia 217
DE - Germania 196
FR - Francia 196
IE - Irlanda 181
KR - Corea 103
FI - Finlandia 97
CA - Canada 71
TR - Turchia 59
ID - Indonesia 52
IN - India 47
UA - Ucraina 47
AR - Argentina 44
NG - Nigeria 44
NL - Olanda 42
BD - Bangladesh 40
AT - Austria 34
JP - Giappone 30
IQ - Iraq 25
MX - Messico 25
PL - Polonia 25
EC - Ecuador 24
ZA - Sudafrica 17
BE - Belgio 15
CO - Colombia 15
ES - Italia 15
UZ - Uzbekistan 15
AZ - Azerbaigian 11
BJ - Benin 11
EG - Egitto 11
MA - Marocco 11
TG - Togo 11
AE - Emirati Arabi Uniti 9
CH - Svizzera 9
HR - Croazia 9
PK - Pakistan 9
VE - Venezuela 9
AL - Albania 8
LT - Lituania 8
CL - Cile 7
PT - Portogallo 7
TN - Tunisia 7
NO - Norvegia 6
NZ - Nuova Zelanda 6
PH - Filippine 6
PY - Paraguay 6
AU - Australia 5
BO - Bolivia 5
JO - Giordania 5
BY - Bielorussia 4
DZ - Algeria 4
IL - Israele 4
JM - Giamaica 4
KZ - Kazakistan 4
LA - Repubblica Popolare Democratica del Laos 4
PE - Perù 4
SA - Arabia Saudita 4
UY - Uruguay 4
BG - Bulgaria 3
DO - Repubblica Dominicana 3
LV - Lettonia 3
MU - Mauritius 3
MY - Malesia 3
OM - Oman 3
QA - Qatar 3
BH - Bahrain 2
CG - Congo 2
DK - Danimarca 2
ET - Etiopia 2
GY - Guiana 2
HN - Honduras 2
LK - Sri Lanka 2
LU - Lussemburgo 2
MK - Macedonia 2
NP - Nepal 2
PS - Palestinian Territory 2
SC - Seychelles 2
SY - Repubblica araba siriana 2
TH - Thailandia 2
TT - Trinidad e Tobago 2
TW - Taiwan 2
BA - Bosnia-Erzegovina 1
BB - Barbados 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
CY - Cipro 1
GA - Gabon 1
GE - Georgia 1
GN - Guinea 1
GR - Grecia 1
GT - Guatemala 1
HU - Ungheria 1
Totale 12.025
Salva come PNG Salva come JPEG
Città #
Ashburn 696
Singapore 654
Moscow 571
San Jose 503
Chandler 428
Southend 424
Dallas 374
Hong Kong 315
Verona 216
Jacksonville 187
Dublin 180
The Dalles 163
Beijing 150
Ho Chi Minh City 97
Los Angeles 87
Princeton 78
Lawrence 71
Ann Arbor 65
Jinan 61
Columbus 59
New York 58
Wilmington 58
Hanoi 57
Dong Ket 56
Nanjing 53
Munich 51
Woodbridge 47
Council Bluffs 46
Istanbul 45
Tianjin 44
Redondo Beach 43
Houston 42
Redmond 42
São Paulo 42
Buffalo 41
Jakarta 40
Abuja 39
Lappeenranta 39
Helsinki 34
London 31
Shenyang 29
Changsha 28
Rome 28
Santa Clara 28
Orem 26
Montreal 25
Nuremberg 25
Tokyo 25
Guangzhou 24
Ningbo 24
Zhengzhou 24
Milan 23
Montréal 23
Sindelfingen 23
Taizhou 22
Haikou 21
Warsaw 21
Chennai 19
Hebei 19
Redwood City 19
Vienna 19
Frankfurt am Main 18
Hangzhou 18
Seattle 18
Atlanta 17
Lancaster 17
Nanchang 17
Seoul 17
Da Nang 16
Rio de Janeiro 16
Amsterdam 14
Jiaxing 14
Washington 14
Brussels 13
Chicago 13
Norwalk 13
Phoenix 13
Brooklyn 12
Mcallen 12
Tashkent 12
Baku 11
Bologna 11
Cotonou 11
Lomé 11
Manchester 11
Stockholm 11
Toronto 11
Turku 11
Dhaka 10
Falls Church 10
Guayaquil 10
Johannesburg 10
Shanghai 10
Biên Hòa 9
Brasília 9
Haiphong 9
Baghdad 8
Belo Horizonte 8
Boston 8
City of London 8
Totale 7.263
Salva come PNG Salva come JPEG
Nome #
Biopsychosocial model of resilience in young adults with multiple sclerosis (BPS-ARMS): an observational study protocol exploring psychological reactions early after diagnosis 302
Can the degree of meningeal inflammation and cortical pathology be used to stratify early progressive MS patients? 226
Cerebrospinal fluid IgM levels in association with inflammatory pathways in multiple sclerosis patients 217
Cerebrospinal fluid inflammatory profile of cognitive impairment in newly diagnosed multiple sclerosis patients 214
The CSF profile linked to cortical damage predicts Multiple Sclerosis activity 213
Dimethyl fumarate: a possible exit strategy from natalizumab treatment in patients with multiple sclerosis at risk for severe adverse events 194
Iron loss of thalamic nuclei evaluated with quantitative susceptibility mapping is related to intrathecal macrophages activity and cortical pathology of multiple sclerosis 194
B cells in multiple sclerosis - from targeted depletion to immune reconstitution therapies 187
CSF parvalbumin levels reflect interneuron loss linked with cortical pathology in multiple sclerosis 183
The prognostic value of white-matter selective double inversion recovery mri sequence in multiple sclerosis: an exploratory study 180
Epilepsy in multiple sclerosis: The role of temporal lobe damage 180
Regional distribution and evolution of grey matter changes in different MS phenotypes: a 5-year longitudinal study 170
Increase of CSF inflammatory profile in a case of highly active multiple sclerosis 168
Iron homeostasis, complement, and coagulation cascade as CSF signature of cortical lesions in early multiple sclerosis 167
Increased cortical lesion load and intrathecal inflammation is associated with oligoclonal bands in multiple sclerosis patients: a combined CSF and MRI study 166
CSF levels of CXCL12 and osteopontin as early markers of primary progressive multiple sclerosis 165
Heterogeneity of cortical lesion susceptibility mapping in multiple sclerosis 162
Changes in cerebrospinal fluid balance of TNF and TNF receptors in naïve multiple sclerosis patients: early involvement in compartmentalised intrathecal inflammation 162
Effect of glatiramer acetate on cerebral grey matter pathology in patients with relapsing-remitting multiple sclerosis 160
Cognitive impairment predicts disability progression and cortical thinning in MS: An 8-year study 159
B-cell enrichment and Epstein-Barr virus infection in inflammatory cortical lesions in secondary progressive multiple sclerosis 158
Meningeal inflammation plays a role in the pathology of primary progressive multiple sclerosis 158
Volume changes of thalamus, hippocampus and cerebellum are associated with specific CSF profile in MS 158
Serum and cerebrospinal neurofilament light chain levels in patients with acquired peripheral neuropathies 157
Cortical grey matter demyelination can be induced by elevated pro-inflammatory cytokines in the subarachnoid space of MOG-immunized rats 156
Increased NK Cell Count in Multiple Sclerosis Patients Treated With Dimethyl Fumarate: A 2-Year Longitudinal Study 152
CSF Parvalbumin Levels at Multiple Sclerosis Diagnosis Predict Future Worse Cognition, Physical Disability, Fatigue, and Gray Matter Damage 150
Regional distribution and evolution of gray matter damage in different populations of multiple sclerosis patients 147
Inflammatory intrathecal profiles and cortical damage in multiple sclerosis 147
Association of Levels of CSF Osteopontin With Cortical Atrophy and Disability in Early Multiple Sclerosis 146
B cell rich meningeal inflammation associates with increased spinal cord pathology in multiple sclerosis 145
Mice repeatedly exposed to Group-A β-Haemolytic Streptococcus show perseverative behaviors, impaired sensorimotor gating, and immune activation in rostral diencephalon 144
Can CSF biomarkers predict future MS disease activity and severity? 144
Increased cortical lesion load and CSF cytokines in oligoclonal band positive MS patients 141
"Ependymal-in" gradient of thalamic damage in progressive multiple sclerosis 139
Exploring the origins of grey matter damage in multiple sclerosis. 137
Interleukin-9 regulates macrophage activation in the progressive multiple sclerosis brain 137
Aging, cellular senescence, and progressive Multiple Sclerosis 136
A gradient of neuronal loss and meningeal inflammation in multiple sclerosis 132
Repeated passive mobilization to stimulate vascular function in individuals of advanced age who are chronically bedridden. A randomized controlled trial 131
Dendritic cells in multiple sclerosis lesions: maturation stage, myelin uptake, and interaction with proliferating T cells 130
Intrathecal versus peripheral inflammatory protein profile in MS patients at diagnosis: a comprehensive investigation on serum and CSF 128
Dysregulated Epstein-Barr virus infection in the multiple sclerosis brain 125
Chronic bedridden condition is reflected by substantial changes in plasma inflammatory profile 123
Potential neuroprotective effect of Fingolimod in multiple sclerosis and its association with clinical variables 123
The vascular side of chronic bed rest: when a therapeutic approach becomes deleterious 122
Intracerebral expression of CXCL13 and BAFF is accompanied by formation of lymphoid follicle-like structures in the meninges of mice with relapsing experimental autoimmune encephalomyelitis 121
Determinants and Biomarkers of Progression Independent of Relapses in Multiple Sclerosis 120
Meningeal inflammation changes the balance of TNF signalling in cortical grey matter in multiple sclerosis 120
A surface-in gradient of thalamic damage evolves in pediatric multiple sclerosis 119
Acute TREM2 inhibition depletes MAFB-high microglia and hinders remyelination 118
Cortical surface-in gradient of alterations in magnetization transfer imaging in association with CSF soluble factors 114
Neuropathological and cerebrospinal fluid correlates of choroid plexus inflammation in progressive multiple sclerosis 113
The cortical damage, early relapses, and onset of the progressive phase in multiple sclerosis 113
Programmed death 1 is highly expressed on CD8+CD57+ T cells in patients with stable multiple sclerosis and inhibits their cytotoxic response to EBV 110
Detection of ectopic B-cell follicles with germinal centers in the meninges of patients with secondary progressive multiple sclerosis 109
Intrathecal Inflammatory Profile and Gray Matter Damage Predict Progression Independent of Relapse Activity in Early Multiple Sclerosis 108
Epstein-Barr virus latent infection and BAFF expression in B cells in the multiple sclerosis brain: implications for viral persistence and intrathecal B-cell activation 108
Inhibition of soluble tumour necrosis factor is therapeutic in experimental autoimmune encephalomyelitis and promotes axon preservation and remyelination 107
Meningeal B-cell follicles in secondary progressive multiple sclerosis associate with early onset of disease and severe cortical pathology 107
Neonatal corticosterone mitigates autoimmune neuropsychiatric disorders associated with streptococcus in mice 107
A disease-specific convergence of host and Epstein-Barr virus genetics in multiple sclerosis 105
Suppression of established experimental autoimmune encephalomyelitis and formation of meningeal lymphoid follicles by lymphotoxin beta receptor-Ig fusion protein 105
Meningeal inflammation is widespread and linked to cortical pathology in multiple sclerosis 104
MRI of cortical lesions and its use in studying their role in MS pathogenesis and disease course 103
Effects of the plasticiser DEHP on lung of newborn rats: catalase immunocytochemistry and morphometric analysis 100
Meningeal inflammation and cortical demyelination in acute multiple sclerosis 99
Impact of neuronal loss on relaxometry and magnetization transfer imaging estimations 98
Detection of Epstein-Barr virus and B-cell follicles in the multiple sclerosis brain: what you find depends on how and where you look 98
The BAFF / APRIL system as therapeutic target in multiple sclerosis 98
Characterization of cortico-meningeal translocator protein expression in multiple sclerosis 97
P2Y12 receptor protein in cortical gray matter lesions in multiple sclerosis 97
Lymphotoxin-alpha expression in the meninges causes lymphoid tissue formation and neurodegeneration 96
Selection of novel reference genes for use in the human central nervous system: a BrainNet Europe Study 96
Intracerebral regulation of immune responses 95
Lymphoid chemokines in chronic neuroinflammation 93
TNF-alpha and metalloproteases as key players in melanoma cells aggressiveness 93
Myeloid cell iron uptake pathways and paramagnetic rim formation in multiple sclerosis 89
Expression of TWEAK and its receptor Fn14 in the multiple sclerosis brain: implications for inflammatory tissue injury 86
Accelerated Cellular Senescence in Progressive Multiple Sclerosis: A Histopathological Study 85
A glia-enriched stem cell 3D model of the human brain mimics the glial-immune neurodegenerative phenotypes of multiple sclerosis 85
The association between neurodegeneration and local complement activation in the thalamus to progressive multiple sclerosis outcome 84
Meningeal inflammation as a driver of cortical grey matter pathology and clinical progression in multiple sclerosis 79
Overexpression of the ubiquitin-editing enzyme A20 in the brain lesions of Multiple Sclerosis patients: moving from systemic to central nervous system inflammation 79
snRNA-seq stratifies multiple sclerosis patients into distinct white matter glial responses 77
Intrathecal inflammation in progressive multiple sclerosis 77
Surface-in pathology in multiple sclerosis: a new view on pathogenesis? 76
High levels of perivascular inflammation and active demyelinating lesions at time of death associated with rapidly progressive multiple sclerosis disease course: a retrospective post-mortem cohort study 72
Editorial: B cells in inflammatory and neurodegenerative diseases of the central nervous system 72
Temporal lobe cortical pathology and inhibitory GABA interneuron cell loss are associated with seizures in multiple sclerosis 68
Mapping Molecular Pathways of Multiple Sclerosis: A Gene Prioritization and Network Analysis of White Matter Pathology Transcriptomics 63
Differences in age-related retinal and cortical atrophy rates in multiple sclerosis 62
Relapsing meningitis and limbic encephalitis in anti-AQP4-Ab-associated neuromyelitis optica spectrum disorder 59
Comparing the pathology, clinical and demographic characteristics of younger and older-onset multiple sclerosis 57
Editorial: Community series in reassessing the immune system contribution in multiple sclerosis: therapeutic target, biomarkers of disease and immune pathogenesis, volume II 48
Blood and CSF biomarkers for multiple sclerosis: emerging clinical applications 44
Unsupervised Clustering Based on Quantitative Magnetic Resonance Imaging Features Contributes to the Characterization of MS White Matter Lesions 39
Choroid plexus volume predicts progression independent of relapse activity in early relapsing multiple sclerosis 35
Quantitative Magnetic resonance imaging lesion features allow machine learning-based classification of MS patients with Progression Independent of Relapse Activity 28
EBV infection and HLA-DR15 jointly drive multiple sclerosis by myelin peptide presentation 18
Totale 12.188
Salva come PNG Salva come JPEG
Categoria #
all - tutte 42.847
article - articoli 41.361
book - libri 0
conference - conferenze 1.486
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 85.694
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021139 0 0 0 0 0 0 0 0 0 0 64 75
2021/2022556 36 171 1 72 18 7 19 40 20 19 30 123
2022/20231.208 86 147 115 223 68 282 22 69 157 4 18 17
2023/2024612 17 50 48 62 74 87 46 50 2 60 84 32
2024/20252.139 75 141 69 345 94 104 88 137 338 156 170 422
2025/20266.118 451 323 392 943 1.563 405 616 357 576 419 73 0
Totale 12.194